Literature DB >> 12861393

Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.

Y Takeda1, K Hiraishi, H Takeda, N Shiobara, H Shibusawa, A R Saniabadi, M Adachi, S Kawata.   

Abstract

OBJECTIVE: Dramatic improvements in clinical symptoms of rheumatoid arthritis and ulcerative colitis were observed after patients received granulocyte and monocyte adsorptive apheresis with a column containing cellulose acetate (CA) beads as adsorptive carriers. This study was to investigate the effect of CA beads on the generation of anti-inflammatory and pro-inflammatory cytokines in human blood.
MATERIALS AND METHODS: We incubated human whole blood with CA beads at 37 degrees C for up to 2 h and measured tumour necrosis factor-alpha (TNF-alpha) interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1ra) produced by leucocytes. IL-1ra was also measured at the inflow and outflow of a column containing CA beads as leucocyte adsorptive carriers for the treatment of patients with ulcerative colitis.
RESULTS: CA beads induced significant release of IL-1ra from leucocytes, but not TNF-alpha or IL-1beta. In contrast, all three cytokines were released when leucocytes were stimulated with lipopolysaccharide. IL-1ra was also markedly elevated in the outflow of the leucocyte apheresis column.
CONCLUSIONS: These results indicate that CA beads selectively induce IL-1ra release from leucocytes which should contribute to the anti-inflammatory effect of granulocyte and monocyte adsorptive apheresis with CA beads as apheresis carriers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861393     DOI: 10.1007/s00011-003-1173-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  6 in total

1.  Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.

Authors:  Wolfgang Kruis; Axel Dignass; Elisabeth Steinhagen-Thiessen; Julia Morgenstern; Joachim Mössner; Stephan Schreiber; Maurizio Vecchi; Alberto Malesci; Max Reinshagen; Robert Löfberg
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis.

Authors:  Grit Waitz; Sebastian Petermann; Stefan Liebe; Joerg Emmrich; Wolfgang Ramlow
Journal:  Dig Dis Sci       Date:  2008-02-06       Impact factor: 3.199

3.  Complement activation is involved in biological responses to leukocyte adsorptive apheresis.

Authors:  Shoichi Nishise; Yuji Takeda; Hiroaki Takeda; Katsuyoshi Ishihama; Tadahisa Fukui; Sumio Kawata
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

4.  Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.

Authors:  Kyoya Sakimura; Toshihide Omori; Etsuro Iwashita; Takeshi Yoshida; Yoshikazu Tsuzuki; Kenji Fujimori; Fumio Konishi; Yukio Yoshida; Hiroo Anzai; Hiromichi Suzuki; Souichi Sugawara; Yuji Takeda; Katsuya Hiraishi; Abbi R Saniabadi; Tatsuo Ide; Soichiro Miura; Shinichi Ota
Journal:  Dig Dis Sci       Date:  2006-08-12       Impact factor: 3.199

Review 5.  Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.

Authors:  Takayuki Yamamoto; Satoru Umegae; Koichi Matsumoto
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Human peripheral neutrophils express functional IL-21 receptors.

Authors:  Yuji Takeda; Hidetoshi Nara; Akemi Araki; Hironobu Asao
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.